HealthEquity (NASDAQ:HQY) Lowered to “Hold” Rating by Wall Street Zen

by · The Cerbat Gem

Wall Street Zen cut shares of HealthEquity (NASDAQ:HQY – Free Report) from a buy rating to a hold rating in a research report sent to investors on Saturday,Wall Street Zen reports.

A number of other research firms also recently commented on HQY. Citizens Jmp boosted their target price on HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research report on Monday, June 1st. Citigroup restated a “market outperform” rating on shares of HealthEquity in a research report on Friday, August 28th. KeyCorp reaffirmed an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. Wells Fargo & Company set a $111.00 price objective on shares of HealthEquity in a research report on Monday, June 1st. Finally, Telsey Advisory Group set a $111.00 price objective on shares of HealthEquity in a research note on Friday, August 28th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $111.87.

View Our Latest Analysis on HealthEquity

HealthEquity Price Performance

HQY stock opened at $96.07 on Friday. The firm has a 50 day moving average of $99.37 and a 200-day moving average of $88.61. The company has a market cap of $7.95 billion, a price-to-earnings ratio of 34.68, a PEG ratio of 1.52 and a beta of 0.22. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.47. HealthEquity has a 12-month low of $72.76 and a 12-month high of $107.62.

HealthEquity (NASDAQ:HQY – Get Free Report) last released its quarterly earnings results on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%.The business had revenue of $350.73 million for the quarter, compared to analysts’ expectations of $349.22 million. The company’s quarterly revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, equities analysts expect that HealthEquity will post 3.93 EPS for the current fiscal year.

Insider Buying and Selling at HealthEquity

In other news, Director Adrian T. Dillon sold 7,632 shares of the company’s stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the sale, the director directly owned 62,395 shares in the company, valued at $6,527,140.95. This represents a 10.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Fiore sold 2,470 shares of the stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $95.00, for a total value of $234,650.00. Following the sale, the executive vice president directly owned 56,643 shares in the company, valued at approximately $5,381,085. The trade was a 4.18% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 12,456 shares of company stock valued at $1,256,664 in the last three months. 1.60% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in shares of HealthEquity during the second quarter worth about $1,018,621,000. California State Teachers Retirement System lifted its stake in shares of HealthEquity by 8,679.7% during the second quarter. California State Teachers Retirement System now owns 8,832,754 shares of the company’s stock valued at $797,774,000 after buying an additional 8,732,150 shares during the period. William Blair Investment Management LLC acquired a new stake in HealthEquity during the fourth quarter worth approximately $169,956,000. Bank of America Corp DE acquired a new stake in HealthEquity during the second quarter worth approximately $103,573,000. Finally, Atalan Capital Partners LP purchased a new stake in HealthEquity in the 2nd quarter worth approximately $82,667,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

About HealthEquity

(Get Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Read More